Sydney, Australia (ABN Newswire) - Melbourne technology firm, Rhinomed (ASX:RNO) is pleased to announce that it has appointed sales and marketing brokerage firm Brand Solutions Australia to represent Mute in the Australian Pharmacy and Grocery channel.

Brand Solutions Australia (BSA) will be targeting over 5,000 Pharmacies nationally and working closely with Rhinomed to establish the Mute technology as the market leading brand within the Australian sleeping aids category.

Aligning sales strategies and customer distribution with the major marketing support that Rhinomed plan to invest in the Mute brand will help to elevate the Mute brand awareness with consumers within the Pharmacy channel.

Brand Solutions Australia (BSA) is a Melbourne based sales and marketing brokerage firm established by seasoned FMCG and pharmacy executives Zack Bozinovski and Thomas Seibel.

BSA works with local and overseas principles that offer unique and first to market products for both the Pharmacy and Grocery channel in Australia. BSA currently work with other leading companies such as Mayne Pharma, Actavis and Vitaminhaus, Rhinomed CEO Michael Johnson commented. "We are excited to be working with BSA. Zach, Tom and the team bring extraordinary experience, long term relationships and a granular understanding of the pharmacy and grocery sector. With a national sales team of 13, BSA provide Rhinomed with the firepower and experience to ensure Mute is able to deliver real value to Australian pharmacies and customers.



About Rhinomed Ltd:

Rhinomed Limited is a medical technology firm that focuses on nasal, respiratory and breathing management technologies. The company is monetising its technology portfolio in the Sport and recreation market, Sleep, Wellbeing and Drug delivery markets.

Rhinomed's technology is designed to radically improve the way you breathe sleep, maintain your health and take medication.

The first product brought to market is the Turbine(TM). A radical nasal technology that improves airflow by an average of 38%, the Turbine(TM) is an internal nasal dilator that has since it's launch in January 2014 in Australia, grown to be widely adopted by leading cyclists and triathletes globally.

Now shipped to over 36 countries and with a growing global distribution base, the Turbine(TM) is providing all those undertaking aerobic activities with an opportunity to breathe better, perform better and get more enjoyment from their sport and exercise.



Source:

Rhinomed Ltd



Contact:

Michael Johnson
CEO & Managing Director
T: +61-3-8416-0900
E: mjohnson@rhinomed.com.au